Massimo Libra Selected Research

Mineral Fibers (Mineral Fiber)

5/2017	Epigenetic alterations and occupational exposure to benzene, fibers, and heavy metals associated with tumor development (Review).
11/2016	Occupational exposure to carcinogens: Benzene, pesticides and fibers (Review).
2/2009	Mineral fiber-mediated activation of phosphoinositide-specific phospholipase c in human bronchoalveolar carcinoma-derived alveolar epithelial A549 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimo Libra Research Topics

Disease

111	Neoplasms (Cancer) 06/2022 - 07/2003
22	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2005
18	Melanoma (Melanoma, Malignant) 03/2022 - 09/2008
12	Urinary Bladder Neoplasms (Bladder Cancer) 05/2020 - 10/2015
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 09/2015
9	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 01/2006
9	Infections 08/2020 - 01/2005
9	Neoplasm Metastasis (Metastasis) 01/2017 - 03/2004
7	Inflammation (Inflammations) 10/2022 - 09/2006
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 03/2004
6	Lymphoma (Lymphomas) 09/2020 - 07/2002
6	Ovarian Neoplasms (Ovarian Cancer) 09/2017 - 05/2003
4	Hypertension (High Blood Pressure) 01/2022 - 10/2015
4	Carcinoma (Carcinomatosis) 12/2019 - 05/2003
4	Carcinogenesis 01/2019 - 01/2006
3	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 03/2011
3	Glioblastoma (Glioblastoma Multiforme) 06/2021 - 01/2019
3	COVID-19 08/2020 - 01/2020
3	Disease Progression 01/2020 - 06/2018
3	Peripheral Arterial Disease 10/2016 - 02/2005
3	Colonic Neoplasms (Colon Cancer) 03/2011 - 02/2003
2	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 10/2015
2	Mouth Neoplasms (Oral Cancer) 11/2020 - 01/2019
2	Adenocarcinoma 01/2020 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 09/2019 - 05/2014
2	Neuroblastoma 08/2019 - 01/2016
2	Hemorrhage 01/2019 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2018 - 01/2016
2	Leukemia 09/2017 - 05/2010
2	Brain Neoplasms (Brain Tumor) 01/2017 - 05/2015
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2017 - 08/2015
2	Mesothelioma 11/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 09/2021 - 11/2008
19	Pharmaceutical PreparationsIBA 12/2020 - 01/2006
17	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2022 - 01/2006
14	MicroRNAs (MicroRNA)IBA 11/2020 - 12/2011
11	Proteins (Proteins, Gene)FDA Link 02/2022 - 02/2006
10	Biological ProductsIBA 01/2019 - 02/2006
9	Immune Checkpoint InhibitorsIBA 09/2021 - 01/2018
9	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 02/2005
8	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 01/2006
8	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2003
7	CytokinesIBA 10/2022 - 01/2006
7	ORALIT (ORS)IBA 12/2019 - 10/2015
6	Interleukin-6 (Interleukin 6)IBA 10/2022 - 09/2006
6	BerberineIBA 01/2022 - 12/2012
5	Transcription Factors (Transcription Factor)IBA 02/2022 - 05/2009
5	Glycogen Synthase Kinase 3IBA 01/2021 - 05/2014
5	EnzymesIBA 03/2016 - 09/2006
4	Monoclonal AntibodiesIBA 09/2019 - 01/2011
4	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 03/2004
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 11/2008
4	Tamoxifen FDA LinkGeneric 01/2018 - 01/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 03/2011
4	AntigensIBA 01/2017 - 01/2005
4	MTOR InhibitorsIBA 11/2016 - 07/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016 - 09/2006
3	PlatinumIBA 12/2019 - 05/2003
3	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 09/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 05/2003
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2006
3	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 03/2008
3	CarcinogensIBA 05/2017 - 01/2014
3	Mineral Fibers (Mineral Fiber)IBA 05/2017 - 02/2009
3	Phosphotransferases (Kinase)IBA 01/2017 - 12/2009
3	OsteopontinIBA 03/2016 - 11/2005
3	Messenger RNA (mRNA)IBA 01/2016 - 03/2004
3	ErbB Receptors (EGF Receptor)IBA 01/2016 - 03/2011
3	NF-kappa B (NF-kB)IBA 09/2015 - 07/2010
3	C-Reactive ProteinIBA 01/2015 - 09/2006
3	Hormones (Hormone)IBA 07/2014 - 06/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2012 - 05/2009
2	raf KinasesIBA 02/2022 - 12/2009
2	PolyphenolsIBA 01/2022 - 02/2021
2	nutlin 3IBA 01/2022 - 01/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021 - 09/2008
2	Protein Isoforms (Isoforms)IBA 09/2021 - 09/2011
2	RNA (Ribonucleic Acid)IBA 06/2021 - 04/2005
2	AntibodiesIBA 01/2021 - 01/2016
2	IsoflavonesIBA 01/2021 - 05/2019
2	Vitamin D FDA LinkGeneric 12/2020 - 01/2017
2	VitaminsIBA 05/2020 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 08/2012
2	Estrogen ReceptorsIBA 01/2020 - 11/2016
2	Protein Kinases (Protein Kinase)IBA 04/2019 - 04/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 08/2015
2	CurcuminIBA 01/2018 - 12/2017
2	Gemcitabine FDA Link 01/2018 - 01/2018
2	ResveratrolIBA 01/2018 - 12/2017
2	Indicators and Reagents (Reagents)IBA 01/2018 - 10/2012
2	Benzene (Benzole)IBA 05/2017 - 11/2016
2	beta CateninIBA 02/2017 - 05/2014

Therapy/Procedure

57	Therapeutics 03/2022 - 05/2003
20	Drug Therapy (Chemotherapy) 01/2020 - 03/2004
9	Immunotherapy 08/2020 - 07/2003
7	Mediterranean Diet 01/2021 - 01/2017
4	Radiotherapy 01/2019 - 11/2011
3	Aftercare (After-Treatment) 01/2018 - 10/2012
2	Oral Diagnosis (Oral Examination) 01/2020 - 01/2019
2	Precision Medicine 01/2017 - 06/2016